Allscripts (MDRX) Tops Q2 EPS by 6c

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $406.2 million versus the consensus estimate of $398.96 million.

• Signed definitive agreement to sell EPSi business unit for $365 million

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Ryan Cohen drops CEO pay award as GameStop pursues eBay acquisition